A
Actuate Therapeutics, Inc. (ACTU)
NGM – Real Time Price. Currency in USD
1.68
-0.28 (-14.29%)
At close: Jun 26, 2026, 4:00 PM EDT
1.79
+0.11 (6.55%)
After-hours: Jun 26, 2026, 6:06 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
1.68
-0.28 (-14.29%)
At close: Jun 26, 2026, 4:00 PM EDT
1.79
+0.11 (6.55%)
After-hours: Jun 26, 2026, 6:06 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $8.1M significantly exceed its total debt $405.0K, ensuring strong financial flexibility
Total current assets $8.5M exceed Total current liabilities $4.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1,127.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$5.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.80 | 6.05 | 9.0 | |
| Quick ratio | 1.80 | 5.63 | 9.0 | |
| Debt to Equity | 0.11 | 0.30 | 9.0 | |
| Debt to Assets | 0.05 | 1.04 | 9.0 | |
| Interest coverage | -1127.21 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -20M | -25M | -25M | -22M | -22M |
| Net Income | -20M | -25M | -27M | -22M | -22M |
| EBITDA | -20M | -25M | -25M | -22M | -22M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 33.94 | 5.5 |
| Next quarter | N/A | 23.59 | 5.5 |
| Current year | N/A | 24.31 | 5.5 |
| Next year | N/A | -5.95 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -23.53 | -19.99 | -34.29 | 3.3 |
| Y/Y | 999 | 10.94 | 25 | -8.62 | 7.0 |
| 3y average | 999 | -4.81 | N/A | -3.47 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |